Singular Genomics Systems, Inc.Singular Genomics Systems, Inc.Singular Genomics Systems, Inc.

Singular Genomics Systems, Inc.

No trades
See on Supercharts
Market capitalization
‪29.26 M‬USD
−1.3030USD
‪−94.82 M‬USD
‪2.91 M‬USD
‪42.42 M‬
Beta (1Y)
2.76

About Singular Genomics Systems, Inc.

CEO
Andrew Spaventa
Headquarters
San Diego
Employees (FY)
265
Founded
2016
ISIN
US82933R1005
FIGI
BBG010WX4GM6
Singular Genomics Systems, Inc. engages in the development and commercialization of proprietary sequencing solutions. It develops two integrated solutions: G4 Instrument and PX Instrument. The G4 Instrument operates as a benchtop next generation sequencer designed to produce fast and accurate genetic sequencing results. The PX Instrument combines single cell and spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution. The company was founded by Eli Glezer, David Barker and Andrew Spaventa in June 2016 and is headquartered in San Diego, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of OMIC is 0.3950 USD — it has increased by 1.57% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Singular Genomics Systems, Inc. stocks are traded under the ticker OMIC.
Singular Genomics Systems, Inc. is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.
OMIC stock is 7.05% volatile and has beta coefficient of 2.76. Check out the list of the most volatile stocks — is Singular Genomics Systems, Inc. there?
One year price forecast for Singular Genomics Systems, Inc. has a max estimate of 0.8500 USD and a min estimate of 0.8500 USD.
OMIC earnings for the last quarter are −0.31 USD per share, whereas the estimation was −0.38 USD resulting in a 18.67% surprise. The estimated earnings for the next quarter are −0.32 USD per share. See more details about Singular Genomics Systems, Inc. earnings.
Singular Genomics Systems, Inc. revenue for the last quarter amounts to ‪462.00 K‬ USD despite the estimated figure of ‪1.28 M‬ USD. In the next quarter revenue is expected to reach ‪829.67 K‬ USD.
Yes, you can track Singular Genomics Systems, Inc. financials in yearly and quarterly reports right on TradingView.
OMIC stock has risen by 1.02% compared to the previous week, the month change is a 23.60% fall, over the last year Singular Genomics Systems, Inc. has showed a 64.09% decrease.
OMIC net income for the last quarter is ‪−23.25 M‬ USD, while the quarter before that showed ‪−22.36 M‬ USD of net income which accounts for −3.98% change. Track more Singular Genomics Systems, Inc. financial stats to get the full picture.
Today Singular Genomics Systems, Inc. has the market capitalization of ‪29.20 M‬, it has decreased by 2.98% over the last week.
No, OMIC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, OMIC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Singular Genomics Systems, Inc. stock right from TradingView charts — choose your broker and connect to your account.
OMIC reached its all-time high on Jun 2, 2021 with the price of 33.3700 USD, and its all-time low was 0.3101 USD and was reached on Nov 10, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 21, 2024, the company has 265.00 employees. See our rating of the largest employees — is Singular Genomics Systems, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Singular Genomics Systems, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Singular Genomics Systems, Inc. stock shows the sell signal. See more of Singular Genomics Systems, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Singular Genomics Systems, Inc. future price: according to them, OMIC price has a max estimate of 0.85 USD and a min estimate of 0.85 USD. Read a more detailed Singular Genomics Systems, Inc. forecast: see what analysts think of Singular Genomics Systems, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Singular Genomics Systems, Inc. EBITDA is ‪−93.68 M‬ USD, and current EBITDA margin is ‪−3.22 K‬%. See more stats in Singular Genomics Systems, Inc. financial statements.